1. Home
  2. DHI vs IQV Comparison

DHI vs IQV Comparison

Compare DHI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

HOLD

Current Price

$139.57

Market Cap

42.6B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$244.30

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHI
IQV
Founded
1978
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6B
36.4B
IPO Year
1992
2013

Fundamental Metrics

Financial Performance
Metric
DHI
IQV
Price
$139.57
$244.30
Analyst Decision
Hold
Buy
Analyst Count
13
15
Target Price
$158.77
$236.93
AVG Volume (30 Days)
2.8M
1.2M
Earning Date
01-20-2026
02-05-2026
Dividend Yield
1.25%
N/A
EPS Growth
N/A
N/A
EPS
11.57
7.30
Revenue
$34,250,400,000.00
$15,904,000,000.00
Revenue This Year
$0.40
$6.15
Revenue Next Year
$5.66
$5.39
P/E Ratio
$12.49
$32.93
Revenue Growth
N/A
3.85
52 Week Low
$110.44
$134.65
52 Week High
$184.55
$241.81

Technical Indicators

Market Signals
Indicator
DHI
IQV
Relative Strength Index (RSI) 33.23 74.40
Support Level $143.18 $221.78
Resistance Level $148.51 $228.28
Average True Range (ATR) 3.33 4.55
MACD -0.76 1.69
Stochastic Oscillator 7.61 89.78

Price Performance

Historical Comparison
DHI
IQV

About DHI D.R. Horton Inc.

With operations in 126 markets across 36 states, D.R. Horton is the leading homebuilder in the United States. It mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: